Briefing: Antimony Corporation (UAMY) Benefited from the Export Restrictions
Strategic angle: Antimony Corporation (UAMY) sees positive impacts from recent export restrictions.
Editorial Staff Mar 10
All Articles
Browse the full archive, newest first.
Briefing: Volkswagen Group profits take big hit on Porsche shift
Strategic angle: Strategic readjustment at Porsche and declining sales in key markets impact VW's profits significantly.
Editorial Staff Mar 10
Briefing: Long lines form at US airports as DHS shutdown slows security checks
Strategic angle: Travelers faced hours-long waits at security checkpoints at airports in Houston and New Orleans due to a partial shutdown of the US Department of Homeland Security.
Editorial Staff Mar 10
Briefing: Trump reiterates threat of a 'friendly takeover' of Cuba as fuel crisis deepens
Strategic angle: The comments come less than a week after Trump suggested that his administration would turn its sights on Havana.
Editorial Staff Mar 10
Briefing: BioNTech Shares Fall After Cofounders Plan Exit, Outlook Misses Forecasts
Strategic angle: BioNTech's stock takes a hit as cofounders announce their departure and the company's outlook fails to meet expectations.
Editorial Staff Mar 10
Briefing: Spirit Airlines to Recall Furloughed Pilots Amid Bankruptcy Exit Plans
Strategic angle: The airline aims to combat pilot attrition by bringing back furloughed aviators as it navigates its financial recovery.
Editorial Staff Mar 10
Briefing: Identity theft can cost you during tax season: It's 'a terrible reverse lottery,' one victim says
Strategic angle: Employment-related identity theft is on the rise. Victims may not find out until tax season.
Editorial Staff Mar 10
Briefing: Amid dueling autism meetings, HHS cancels
Strategic angle: Epilepsy med response, a long-awaited fix to the kidney transplant system, and more health news
Editorial Staff Mar 10
Briefing: Investors’ Confidence Boosted Perimeter Solutions (PRM) in Q4
Strategic angle: Investors’ confidence has positively impacted Perimeter Solutions (PRM) in the fourth quarter.
Editorial Staff Mar 10
Briefing: Here is Why CRISPR Therapeutics (CRSP) Appears so Good
Strategic angle: An analysis of CRISPR Therapeutics' potential in the market.
Editorial Staff Mar 10